Skip to main content

Peer Review reports

From: Incidence and risk of hypertension associated with PARP inhibitors in cancer patients: a systematic review and meta-analysis

Original Submission
15 Nov 2022 Submitted Original manuscript
1 Dec 2022 Reviewed Reviewer Report
18 Dec 2022 Reviewed Reviewer Report - Madan G. Kundu
27 Dec 2022 Reviewed Reviewer Report
8 Jan 2023 Author responded Author comments - Yaling Li
Resubmission - Version 2
8 Jan 2023 Submitted Manuscript version 2
9 Jan 2023 Author responded Author comments - Yaling Li
Resubmission - Version 3
9 Jan 2023 Submitted Manuscript version 3
Publishing
20 Jan 2023 Editorially accepted
31 Jan 2023 Article published 10.1186/s12885-023-10571-5

You can find further information about peer review here.

Back to article page